Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Shujing Liu, Michael T. Tetzlaff, Tao Wang, Xiang Chen, Ruifeng Yang, Suresh M. Kumar, Adina Vultur, Pengxiang Li, James S. Martin, Meenhard Herlyn, Ravi Amaravadi, Bin Li, Xiaowei Xu
Published Dec 5, 2017 · Vol. 8, No. 70 · pp. 115140-115152
Christian D. Fankhauser, Peter J. Schüffler, Silke Gillessen, Aurelius Omlin, Niels J. Rupp, Jan H. Rueschoff, Thomas Hermanns, Cedric Poyet, Tullio Sulser, Holger Moch, Peter J. Wild
Published Dec 4, 2017 · Vol. 9, No. 12 · pp. 10284-10293
Monika Bhardwaj, Hee Jun Cho, Souren Paul, Rekha Jakhar, Imran Khan, Seon-Jin Lee, Bo-Yeon Kim, Manigandan Krishnan, Tejinder Pal Khaket, Hee Gu Lee, Sun Chul Kang
Published Dec 4, 2017 · Vol. 9, No. 3 · pp. 3278-3291